Tegmine Therapeutics
Overview
TegMine Therapeutics is a biotechnology company focused on developing antibody-based therapies targeting cancer-associated glycans and glycoproteins. Their proprietary TegMiner™ platform enables the discovery of unique tumor-specific glycan epitopes, facilitating the creation of highly selective cancer treatments.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Tegmine Therapeutics in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Tegmine Therapeutics? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.